Overview: Urine Bile Salt TestIntroduction: The Urine Bile Salt Test detects bile salts in urine to diagnose liver disorders, causing jaundice. Following 2023 AASLD guidelines, it uses biochemical methods for high specificity, supporting liver screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in biochemistry for patients with suspected liver dysfunction.
Other Names: Urine Bile Salt Assay, Bile Acid Urine Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Bile salt testing began in the 1970s with liver disease research. Biochemical methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects bile salts in urine to diagnose liver disorders, guides treatment, and evaluates patients with jaundice.
Test Parameters: 1. Bile Salt Presence
Pretest Condition: No fasting required. Collect random urine. Report history of jaundice or liver symptoms.
Specimen: Random Urine (sterile container, 5-20 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document jaundice, abdominal pain, or history of liver disorders. Include current medications, especially hepatotoxic drugs.
Consent: Written consent required, detailing the tests purpose, liver disorder implications, and risks of sample collection.
Procedural Considerations: Uses chemical assays or spectrometry to detect bile salts in urine. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for liver disease diagnosis.
Factors Affecting Result Accuracy: Improper urine collection or light exposure can affect results. Medications may alter bile salt levels.
Clinical Significance: Positive bile salts confirm liver dysfunction, guiding further testing or therapy. Negative results may require liver function tests.
Specialist Consultation: Consult a hepatologist for result interpretation and treatment planning.
Additional Supporting Tests: Liver function tests, bilirubin levels, or liver imaging to confirm liver disorder diagnosis.
Test Limitations: Non-specific for liver disease cause; clinical correlation is needed. Sample quality affects sensitivity.
References: AASLD Liver Guidelines, 2023; Hepatology, Lindor KD, 2022.
